B.V. Offersen

3.3k total citations
15 papers, 279 citations indexed

About

B.V. Offersen is a scholar working on Cancer Research, Radiology, Nuclear Medicine and Imaging and Radiation. According to data from OpenAlex, B.V. Offersen has authored 15 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Radiation. Recurrent topics in B.V. Offersen's work include Breast Cancer Treatment Studies (6 papers), Advanced Radiotherapy Techniques (4 papers) and Medical Imaging Techniques and Applications (3 papers). B.V. Offersen is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Advanced Radiotherapy Techniques (4 papers) and Medical Imaging Techniques and Applications (3 papers). B.V. Offersen collaborates with scholars based in Denmark, United Kingdom and Netherlands. B.V. Offersen's co-authors include Jens Overgaard, B Nerstrøm, Michael Borre, Philip Poortmans, Charlotte E. Coles, L. Boersma, Sara Lightowlers, Navita Somaiah, Alain Fourquet and Anna M. Kirby and has published in prestigious journals such as Cancer Research, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

B.V. Offersen

15 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.V. Offersen Denmark 4 160 133 89 79 50 15 279
Vérane Achard Switzerland 10 263 1.6× 71 0.5× 79 0.9× 54 0.7× 87 1.7× 37 359
Roy Vergis United Kingdom 4 178 1.1× 166 1.2× 113 1.3× 43 0.5× 51 1.0× 6 300
Emily S. Weg United States 6 204 1.3× 107 0.8× 63 0.7× 38 0.5× 82 1.6× 23 266
Kevin Lee Min Chua Singapore 10 211 1.3× 45 0.3× 52 0.6× 66 0.8× 141 2.8× 30 341
Selina Kiefer Germany 11 302 1.9× 56 0.4× 71 0.8× 201 2.5× 93 1.9× 16 448
Charles R. Sikes United States 10 262 1.6× 72 0.5× 122 1.4× 84 1.1× 175 3.5× 12 402
Natalie Charnley United Kingdom 10 143 0.9× 63 0.5× 69 0.8× 95 1.2× 87 1.7× 32 295
Xiaoqing Xu China 12 67 0.4× 97 0.7× 105 1.2× 46 0.6× 126 2.5× 28 298
Lorenza Marino Italy 10 78 0.5× 73 0.5× 26 0.3× 65 0.8× 81 1.6× 18 216
Ronan Tanguy France 10 229 1.4× 39 0.3× 85 1.0× 62 0.8× 80 1.6× 30 322

Countries citing papers authored by B.V. Offersen

Since Specialization
Citations

This map shows the geographic impact of B.V. Offersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.V. Offersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.V. Offersen more than expected).

Fields of papers citing papers by B.V. Offersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.V. Offersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.V. Offersen. The network helps show where B.V. Offersen may publish in the future.

Co-authorship network of co-authors of B.V. Offersen

This figure shows the co-authorship network connecting the top 25 collaborators of B.V. Offersen. A scholar is included among the top collaborators of B.V. Offersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.V. Offersen. B.V. Offersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ravkilde, Thomas, et al.. (2021). OC-0425 Dosimetric effects of national guidelines in breast cancer radiotherapy 2008-2016 (DBCG RT-Nation). Radiotherapy and Oncology. 161. S324–S325. 1 indexed citations
2.
Overgaard, Marie, Trine Tramm, Inger Højris, et al.. (2020). OC-0325: Postmastectomy RT in high-risk breast cancer. A 30-year update of the DBCG 82bc randomized trial.. Radiotherapy and Oncology. 152. S171–S171. 1 indexed citations
3.
Marta, Gustavo Nader, Orit Kaidar‐Person, Anna M. Kirby, et al.. (2020). The Financial Impact on Reimbursement of Moderately Hypofractionated Postoperative Radiation Therapy for Breast Cancer: An International Consortium Report. Clinical Oncology. 33(5). 322–330. 25 indexed citations
4.
Offersen, B.V., et al.. (2020). OC-0224: Fully automated heart dose calculation from cine MV images recorded during breast cancer treatments. Radiotherapy and Oncology. 152. S114–S115. 1 indexed citations
5.
Lorenzen, Ebbe Laugaard, Esben Svitzer Yates, Carmel Anandadas, et al.. (2019). PV-0046 Patient selection for proton therapy of early breast cancer - the DBCG phase II study strategy. Radiotherapy and Oncology. 133. S15–S17. 1 indexed citations
6.
Offersen, B.V., Morten Holtegaard Nielsen, Mechthild Krause, et al.. (2018). OC-0596: Hypo- vs normofractionated radiation of early breast cancer in the randomized DBCG HYPO trial. Radiotherapy and Oncology. 127. S312–S312. 2 indexed citations
7.
Lightowlers, Sara, L. Boersma, Alain Fourquet, et al.. (2017). Preoperative breast radiation therapy: Indications and perspectives. European Journal of Cancer. 82. 184–192. 40 indexed citations
8.
Offersen, B.V., Morten Holtegaard Nielsen, Martín Krause, et al.. (2017). Hypo- vs normofractionated radiation therapy of early stage breast cancer in the randomized DBCG HYPO trial. European Journal of Cancer. 72. S9–S10. 1 indexed citations
9.
Bodilsen, Anne, Karsten Bjerre, B.V. Offersen, et al.. (2016). Abstract S2-01: Importance of margin width and re-excision in breast conserving treatment of early breast cancer; a Danish breast cancer cooperative group study of 11,900 women. Cancer Research. 76(4_Supplement). S2–1. 2 indexed citations
10.
Overgaard, Jens, et al.. (2016). EP-1155: Radiation-induced morbidity evaluated by high-frequency ultrasound: a pilot study. Radiotherapy and Oncology. 119. S551–S552. 1 indexed citations
11.
Offersen, B.V., et al.. (2015). PO-0684: Morbidity after regional nodes radiotherapy in early breast cancer patients having axillary lymph node dissection. Radiotherapy and Oncology. 115. S335–S335. 1 indexed citations
12.
Thorsen, Lise Bech Jellesmark, Machteld van den Berg, I. Jensen, et al.. (2014). OC-0148: Improved survival with internal mammary node irradiation: a prospective study on 3,072 breast cancer patients. Radiotherapy and Oncology. 111. S57–S57. 3 indexed citations
13.
Bang, Tami J., et al.. (2012). PO-0954 ACUTE MORBIDITY IN PATIENTS WITH EARLY BREAST CANCER IN ADJUVANT RADIOTHERAPY IN THE DBCG HYPO AND DBCG PBI PROTOCOLS. Radiotherapy and Oncology. 103. S375–S376. 5 indexed citations
14.
Ejlertsen, Bent, Peer Christiansen, Karsten Bjerre, et al.. (2011). S37 Characteristics of breast cancer patients unlikely to benefit from adjuvant therapy. The Breast. 20. S14–S14. 1 indexed citations
15.
Borre, Michael, B.V. Offersen, B Nerstrøm, & Jens Overgaard. (1998). Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting. British Journal of Cancer. 78(7). 940–944. 194 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026